Recently, advances in sequencing technology have allowed a large number ofde novo and inherited GluN2A mutations to be identified in individuals with a range of neurodevelopmental disorders, including epilepsy, intellectual disability, autism and schizophrenia (Burnashev & Szepetowski, 2015). The gene discussed is GRIN2A; the disease is epilepsy.